Aeglea BioTherapeutics | Investor Presentation Deck | 22 slides · page 12 of 22
The slide uses a map to visualize patient prevalence estimates in specific addressable markets.
Pitch deck · market_sizing · size_opportunity · dense density
Slide locked Sign in to view
Slide schematic 6/6
callout 1/1 image 1/1 list 1/1 paragraph 1/1 source-note 1/1 title 1/1
Components 6
primary map bullet paragraph source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1